SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Opexa Therapeutics, Inc. – ‘8-K’ for 6/4/04

On:  Friday, 6/4/04, at 12:59pm ET   ·   For:  6/4/04   ·   Accession #:  1015402-4-2492   ·   File #:  0-25513

Previous ‘8-K’:  ‘8-K/A’ on 12/14/99 for 11/22/99   ·   Next:  ‘8-K’ on / for 9/21/04   ·   Latest:  ‘8-K’ on 11/20/23 for 11/17/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/04/04  Opexa Therapeutics, Inc.          8-K:1,5,7,8 6/04/04    8:330K                                   Summit Fin’l Printing/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                        41    176K 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,     17    115K 
                          Liquidation or Succession                              
 3: EX-10.2     Material Contract                                     16     51K 
 4: EX-10.3     Material Contract                                      9     36K 
 5: EX-10.4     Material Contract                                      9     36K 
 6: EX-10.5     Material Contract                                      7     31K 
 7: EX-10.6     Material Contract                                      7     31K 
 8: EX-10.7     Material Contract                                      7     31K 




        
Filing Submission 0001015402-04-002492 – SGML Text

Original SGML Text submitted by:  Summit Financial Disclosure, LLC/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 12:49:57.3pm ET